Evaluate Severe Hepatic Impairment on Dacomitinib PK

Clinical trial NCT03865446 · COMPLETED

Trial details

NCT number: NCT03865446
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hepatic Impairment

Start date: 2019-04-05
Primary completion: 2019-10-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.